Literature DB >> 9203065

beta-Galactosidase gene mutations in patients with slowly progressive GM1 gangliosidosis.

E M Kaye1, C Shalish, J Livermore, H A Taylor, R E Stevenson, X O Breakefield.   

Abstract

Three unrelated North American cases with slowly progressive forms of GM1 gangliosidosis were found to have two unique point mutations and a 9 bp insertion in the coding region of the gene encoding beta-galactosidase. Case 1 was noted to have a 9 bp insertion ¿CAGAATTTT¿ on one allele between nucleotides 730 and 731 with no other mutations identified in the other allele. In case 2, two point mutations were found: a unique G-->A transition at nucleotide 602 causing an Arg-->His substitution in codon 201 (mutation R201H); and a previously identified G-->T transition at nucleotide 1527 causing a Trp-->Cys substitution in codon 509 (mutation W509C), which has been noted in adult and chronic forms of GM1 gangliosidosis. Case 3 had a unique point mutation (A-->G transition at nucleotide 797) resulting in a Asn-->Ser amino acid substitution in codon 266 (mutation N266S), with no other mutations found in the same or the other allele. Single-strand conformation polymorphism performed on over 100 controls did not demonstrate the presence of the point mutations R201H or N266S. Also, the mutant proteins coded by the two point mutations did not show enzymatic activity in the Cos-1 cell expression system confirming that these mutations are associated with low enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203065     DOI: 10.1177/088307389701200404

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  13 in total

1.  β-Galactosidosis in Patient with Intermediate GM1 and MBD Phenotype.

Authors:  Tereza Moore; Jonathan A Bernstein; Sylvie Casson-Parkin; Tina M Cowan
Journal:  JIMD Rep       Date:  2012-04-22

2.  Fluorous iminoalditols act as effective pharmacological chaperones against gene products from GLB₁ alleles causing GM1-gangliosidosis and Morquio B disease.

Authors:  Katrin M Fantur; Tanja M Wrodnigg; Arnold E Stütz; Bettina M Pabst; Eduard Paschke
Journal:  J Inherit Metab Dis       Date:  2011-10-28       Impact factor: 4.982

Review 3.  The natural history of Type 1 infantile GM1 gangliosidosis: A literature-based meta-analysis.

Authors:  Frederick M Lang; Paul Korner; Mark Harnett; Ajith Karunakara; Cynthia J Tifft
Journal:  Mol Genet Metab       Date:  2019-12-30       Impact factor: 4.797

4.  Primary and secondary elastin-binding protein defect leads to impaired elastogenesis in fibroblasts from GM1-gangliosidosis patients.

Authors:  Anna Caciotti; Maria Alice Donati; Tiziana Bardelli; Alessandra d'Azzo; Graziella Massai; Luciana Luciani; Enrico Zammarchi; Amelia Morrone
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

5.  The treatment of juvenile/adult GM1-gangliosidosis with Miglustat may reverse disease progression.

Authors:  Federica Deodato; Elena Procopio; Angelica Rampazzo; Roberta Taurisano; Maria Alice Donati; Carlo Dionisi-Vici; Anna Caciotti; Amelia Morrone; Maurizio Scarpa
Journal:  Metab Brain Dis       Date:  2017-06-03       Impact factor: 3.584

6.  Isolation and characterization of the normal canine beta-galactosidase gene and its mutation in a dog model of GM1-gangliosidosis.

Authors:  Z H Wang; B Zeng; H Shibuya; G S Johnson; J Alroy; G M Pastores; S Raghavan; E H Kolodny
Journal:  J Inherit Metab Dis       Date:  2000-09       Impact factor: 4.982

7.  Exome sequencing as a diagnostic tool in a case of undiagnosed juvenile-onset GM1-gangliosidosis.

Authors:  Tyler Mark Pierson; David A Adams; Thomas Markello; Gretchen Golas; Sandra Yang; Murat Sincan; Dimitre R Simeonov; Karin Fuentes Fajardo; Nancy F Hansen; Praveen F Cherukuri; Pedro Cruz; Jamie K Teer; James C Mullikin; Cornelius F Boerkoel; William A Gahl; Cynthia J Tifft
Journal:  Neurology       Date:  2012-06-06       Impact factor: 9.910

8.  Modulating action of the new polymorphism L436F detected in the GLB1 gene of a type-II GM1 gangliosidosis patient.

Authors:  Anna Caciotti; Tiziana Bardelli; John Cunningham; Alessandra D'Azzo; Enrico Zammarchi; Amelia Morrone
Journal:  Hum Genet       Date:  2003-03-19       Impact factor: 4.132

9.  Discovery and investigation of misincorporation of serine at asparagine positions in recombinant proteins expressed in Chinese hamster ovary cells.

Authors:  Dingyi Wen; Malgorzata M Vecchi; Sheng Gu; Lihe Su; Jana Dolnikova; Yao-Ming Huang; Susan F Foley; Ellen Garber; Nels Pederson; Werner Meier
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

10.  GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings.

Authors:  Anna Caciotti; Scott C Garman; Yadilette Rivera-Colón; Elena Procopio; Serena Catarzi; Lorenzo Ferri; Carmen Guido; Paola Martelli; Rossella Parini; Daniela Antuzzi; Roberta Battini; Michela Sibilio; Alessandro Simonati; Elena Fontana; Alessandro Salviati; Gulcin Akinci; Cristina Cereda; Carlo Dionisi-Vici; Francesca Deodato; Adele d'Amico; Alessandra d'Azzo; Enrico Bertini; Mirella Filocamo; Maurizio Scarpa; Maja di Rocco; Cynthia J Tifft; Federica Ciani; Serena Gasperini; Elisabetta Pasquini; Renzo Guerrini; Maria Alice Donati; Amelia Morrone
Journal:  Biochim Biophys Acta       Date:  2011-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.